Kahimmune Therapeutics has signed an exclusive licensing agreement with Gustave [...]

M42’s Imperial College London Diabetes & Endocrine Centre and Medtronic [...]

A new preclinical study using a porcine skin model has [...]

The European Medicines Agency’s Committee for Medicinal Product for Human [...]

Biocomposites has launched its SYNICEM antibiotic-loaded preformed spacers in Canada, [...]

Boehringer Ingelheim has reported Phase 2 clinical trial results showing [...]

En Carta Diagnostics has received FDA Breakthrough Device Designation for [...]

TECregen has appointed Dr Klaas Zuideveld as chief executive officer [...]

Skyhawk Therapeutics has reported positive nine-month interim results from its [...]

iXCells Biotechnologies and Rosebud Biosciences have announced a partnership to [...]